Infinity Pharmaceuticals, Inc.
INFIDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001113148
Infinity Pharmaceuticals, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Sep 12, 2023; 45 institutions reported holding it in 13F filings for Q2 2023, worth $4.23M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Infinity Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +11 vs. Q2 2021
- Shares held
- 46.9M
- +3.25M (+7.4%) vs. Q2 2021
- Total value
- $160.5M
- +$29.9M (+22.9%) vs. Q2 2021
- New holders
- 25
- 29 more added
- Sold out
- 14
- 29 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INFI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 3 | $15 |
| Q3 2023 | 3 | $2.90K |
| Q2 2023 | 45 | $4.23M |
| Q1 2023 | 53 | $3.10M |
| Q4 2022 | 68 | $13.9M |
| Q3 2022 | 76 | $36.8M |
| Q2 2022 | 78 | $19.0M |
| Q1 2022 | 93 | $44.3M |
| Q4 2021 | 97 | $93.8M |
| Q3 2021 | 107 | $160.5M |
| Q2 2021 | 97 | $130.9M |
| Q1 2021 | 83 | $135.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Infinity Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Assenagon Asset Management S.A. | 1,758,207 | $6.01M | 0.02% | −5,635−0.3% | Reduced |
| D. E. Shaw & Co., Inc. | 2,227,534 | $7.62M | 0.01% | +2,119,509+1,962.1% | Added |
| Polar Capital Holdings Plc | 2,500,000 | $8.55M | 0.05% | +2,500,000 | New |
| Millennium Management LLC | 2,951,936 | $10.1M | 0.01% | −96,497−3.2% | Reduced |
| Vanguard Group Inc | 5,558,159 | $19.0M | 0.00% | +1,175,354+26.8% | Added |
| BlackRock Inc. | 5,983,489 | $20.5M | 0.00% | −57,855−1.0% | Reduced |
| BVF Inc | 8,383,645 | $28.7M | 1.12% | 00.0% | Unchanged |
| Consonance Capital Management LP | 0 | $0 | 0.00% | −3,766,817−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −934,327−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −517,500−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −100,200−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −90,500−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −45,525−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −27,542−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −26,469−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −12,844−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −6,300−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,986−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,507−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |